1-9 of 9
Walter Fiedler, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Significance and Target Potential of Axl in Acute Myeloid Leukemia

Alexander Schultze, M.D., M.Sc., Isabel Ben-Batalla, Ph.D., Michael Heuser, M.D., Kristoffer Weber, Ph.D., Robert Erdmann, Ph.D., Sacha Holland, Ph.D., Stefanie Sawall, Helena Fritz, M.Sc., Marc Tjwa, M.D., Ph.D., Thomas Schmidt, M.D., Walter Fiedler, M.D., Boris Fehse, Ph.D., Bjorn Dahlback, M.D., Klaus Pantel, M.D., Ph.D., Jürgen Krauter, Arnold Ganser, MD, Carsten Bokemeyer, M.D., Sonja Loges, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 940.
https://doi.org/10.1182/blood.V118.21.940.940
Published: 2011
Journal Articles

Gremlin-1 Is Overexpressed in Endothelial Cells of Patients with Loeys-Dietz Syndrome Due to Dysregulation of TGF-β Signalling,

Jasmin Wellbrock, PhD, Sara Sheikhzadeh, MD, Veronika Bonk, Leticia Oliveira-Ferrer, PhD, Kristin Klaetschke, Thomas Streichert, MD, Carsten Bokemeyer, M.D., Yskert von Kodolitsch, MD, Walter Fiedler, M.D.
Journal: Blood
Blood (2011) 118 (21): 3269.
https://doi.org/10.1182/blood.V118.21.3269.3269
Published: 2011
Journal Articles

Expression of Gli2, a Downstream Mediator of the Activated Hedgehog Pathway, Represents a Negative Prognostic Marker in AML,

Walter Fiedler, M.D., Gabi Vohwinkel, MSc, Juergen Krauter, MD, Eik Vettorazzi, MSc, Sonja Loges, M.D., Ph.D., Livia Fuhrmann, Patrizia Seyfert, Carsten Bokemeyer, M.D., Jasmin Wellbrock, PhD
Journal: Blood
Blood (2011) 118 (21): 3535.
https://doi.org/10.1182/blood.V118.21.3535.3535
Published: 2011
Journal Articles

PHA-680626 Exhibits Anti-Proliferative and Pro-Apoptotic Activity on Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines and Primary CD34+ Cells by Inhibition of Both Bcr-Abl Tyrosine Kinase and Aurora Kinases.

Artur Gontarewicz, MD, Stefan Balabanov, M.D., Ph.D, Gunhild Keller, M.D., Jens Panse, M.D., Mirja Bernhardt, Carsten Bokemeyer, M.D., Walter Fiedler, M.D., Jurgen Moll, Ph.D., Tim Brummendorf, M.D.
Journal: Blood
Blood (2007) 110 (11): 4568.
https://doi.org/10.1182/blood.V110.11.4568.4568
Published: 2007
Journal Articles

Simultaneous Targeting of Aurora Kinases and Bcr-Abl by the Small Molecule Inhibitor PHA-739358 Is Effective in Imatinib-Resistant Mutations Including T315I.

Artur Gontarewicz, MD, Stefan Balabanov, M.D., Ph.D., Gunhild Keller, M.D., Riccardo Colombo, Ph.D., Alessio Graziano, Ph.D, Carsten Bokemeyer, M.D., Walter Fiedler, M.D., Jurgen Moll, Ph.D., Tim Brummendorf, M.D.
Journal: Blood
Blood (2007) 110 (11): 1042.
https://doi.org/10.1182/blood.V110.11.1042.1042
Published: 2007
Journal Articles

Treatment of Patients up to 60 Years with High Risk AML: Final Results of the AML SHG-Hannover 01/99 Trial.

Jürgen Krauter, MD, Gerhard Heil, M.D., Dieter Hoelzer, M.D., Oliver G. Ottmann, M.D., Hans Martin, M.D., Michael Lubbert, M.D., Jurgen Finke, M.D., Wolfgang F.W. Heit, M.D., Walter Fiedler, M.D., Lothar Kanz, M.D., Gunter Schlimok, M.D., Hartmut H. Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Arnold Ganser, M.D.
Journal: Blood
Blood (2006) 108 (11): 433.
https://doi.org/10.1182/blood.V108.11.433.433
Published: 2006
Journal Articles

Prospective Randomized Comparison of High Dose AraC and AutoPBSCT as Late Consolidation for Patients ≤60 Years with Standard Risk AML: Final Results of the AML SHG-Hannover 01/99 Trial.

Arnold Ganser, MD, Jürgen Krauter, M.D., Dieter Hoelzer, M.D., Oliver G. Ottmann, M.D., Hans Martin, M.D., Michael Lubbert, M.D., Jurgen Finke, M.D., Wolfgang F.W. Heit, M.D., Walter Fiedler, M.D., Lothar Kanz, M.D., Gunter Schlimok, M.D., Hartmut H. Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Gerhard Heil, M.D.
Journal: Blood
Blood (2006) 108 (11): 607.
https://doi.org/10.1182/blood.V108.11.607.607
Published: 2006
Journal Articles

Late Consolidation for Patients with Standard Risk AML up to 60 Years: Results of a Prospective Randomized Comparison of High Dose AraC and Autologous PBSCT.

Arnold Ganser, M.D., Jürgen Krauter, M.D., Dieter Hoelzer, M.D., Oliver Ottmann, M.D., Hans Martin, M.D., Michael Lübbert, M.D., Jürgen Finke, M.D., Wolf Heit, M.D., Walter Fiedler, M.D., Dieter Hossfeld, M.D., Lothar Kanz, M.D., Günter Schlimok, M.D., Hartmut Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Gerhard Heil, M.D.
Journal: Blood
Blood (2004) 104 (11): 145.
https://doi.org/10.1182/blood.V104.11.145.145
Published: 2004
Journal Articles

Treatment of Adult Patients with High Risk Acute Myeloblastic Leukemia up to 60 Years: Role of Consolidation Therapy within a Prospective Multicenter Trial.

Jürgen Krauter, M.D., Gerhard Heil, M.D., Dieter Hoelzer, M.D., Oliver Ottmann, M.D., Hans Martin, M.D., Michael Lübbert, M.D., Jürgen Finke, M.D., Wolf Heit, M.D., Walter Fiedler, M.D., Dieter Hossfeld, M.D., Lothar Kanz, M.D., Günter Schlimok, M.D., Hartmut Kirchner, M.D., Aruna Raghavachar, M.D., Wolfram Brugger, M.D., Arnold Ganser, M.D.
Journal: Blood
Blood (2004) 104 (11): 618.
https://doi.org/10.1182/blood.V104.11.618.618
Published: 2004